TLSA Insider Trading Activity and SEC Form 4 Filings
TLSA insider trading summary
Over the past 12 months, insiders at Tiziana Life Sciences Ltd (TLSA) reported 5 open-market purchases worth $1.0M by 2 insiders and no sales on SEC Form 4. Net insider buying was $1.0M.
Latest TLSA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Ivor Elrifi | Chief Executive Officer | Buy | $238K (237,616 @ $1.00) |
| Aug 4, 2026 | Ivor Elrifi | Chief Executive Officer | Buy | $81K (83,807 @ $0.97) |
| Aug 3, 2026 | Ivor Elrifi | Chief Executive Officer | Buy | $667K (667,000 @ $1.00) |
| Jul 21, 2026 | Gabriele M Cerrone | Director | Buy | $42K (42,357 @ $0.99) |
| Jun 12, 2026 | Gabriele M Cerrone | Director | Buy | $17K (15,000 @ $1.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.